Navigation Links
Deafness and seizures result when mysterious protein deleted in mice
Date:1/24/2008

Scientists have discovered that mice genetically engineered to lack a particular protein in the brain have profound deafness and seizures. The finding suggests a pathway, they say, for exploring the hereditary causes of deafness and epilepsy in humans.

More broadly, the discovery provides an entry point for gaining new insight into the role of glutamate, the chemical messenger carried by the protein, says the team, led by scientists at the University of California, San Francisco. Glutamate is involved in virtually every brain function, including sensory perception, learning and memory.

The missing protein is a particular vesicular neurotransmitter transporter, a machine within nerve cells that ferries chemical messengers, or neurotransmitters, from the fluid-filled cytoplasm into vesicles that are positioned at the tips of nerve cells and serve to release neurotransmitters onto neighboring cells. Transporters and neurotransmitters work together to make possible essentially all neural communication in the brain.

While the neurotransmitter glutamate is the major excitatory messenger in the brain, the neurotransmitter GABA is the major inhibitory messenger, sending signals that reduce excitation and anxiety. Two other neurotransmitters, dopamine and serotonin, modulate the activity of neural circuits to influence mood, sleep and other aspects of behavior.

Scientists have known for several years about two vesicular glutamate transporters, VGLUT1 and VGLUT2. As would be predicted, they are expressed on nerve cells that release glutamate. More recently, scientists have identified VGLUT3. To their surprise, they have discovered that VGLUT3 is expressed primarily by nerve cells that release GABA, serotonin and acetylcholine, another neurotransmitter. VGLUT3 is also released in some non-nerve cells, in tissues outside the brain. These findings led scientists to suspect that VGLUT3 might support some function other than neurotransm
'/>"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Former Sufferer of Rare Disease Called Musicogenic Epilepsy Thanks LIJ Medical Team That Ended Her Seizures and Gave Her Back the Gift of Music
2. UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy
3. Some Epilepsy Patients Not Always Aware of Seizures
4. Lamotrigine May Reduce Epilepsy Seizures
5. Implantable device designed to detect, stop seizures under study at MCG
6. Alzheimers Patients May Suffer Silent Seizures
7. BD Announces Results For First Fiscal Quarter
8. WellPoint Reports Fourth Quarter and Full Year 2007 Results
9. Coherent, Inc. to Webcast First Fiscal Quarter 2008 Results
10. Pharmacyclics Announces Conference Call to Discuss Second Quarter 2008 Financial Results
11. Cardica to Announce Fiscal 2008 Second Quarter Financial Results on Thursday, January 24, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Presently, disposable medical ... healthcare equipment and supplies segment. During the past two ... steady growth (on an average 12.5% per year), primarily ... settings. Currently, the US is the largest market for ... share of 40%. The second position is held by ...
(Date:7/11/2014)... -- Researchers from The Miriam Hospital have found ... have significantly higher rates of smoking than those ... were less likely to attempt quitting than those ... not be sufficient for this population. The study ... of print in the American Journal of ...
(Date:7/11/2014)... PULLMAN, Wash.The largest study of its kind has ... suite of advantages over their conventional counterparts, including ... , The study looked at an unprecedented 343 ... of organic and conventional plant-based foods, including fruits, ... meta-analysis techniques to quantify differences between organic and ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Delaying surgery to ... main ligament in the middle of the knee -- could ... They analyzed the medical records of 130 patients, aged ... patients, 62 had surgery less than six weeks after their ... the others had surgery more than three months after their ...
(Date:7/11/2014)... 11, 2014 (HealthDay News) -- Prostate cancer patients are ... less effective treatment and die sooner if they also ... data from more than 41,200 American men who were ... They followed them through 2009. Nearly 1,900 of the ... years before their prostate cancer was discovered. "Men ...
Breaking Medicine News(10 mins):Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Depression May Make It Harder to Beat Prostate Cancer 2
... BOSTON--A surprise discovery -- that calorie-burning brown fat can be ... the prospect of new ways to fight obesity and overweight, ... Aug. 21 issue of the journal Nature, the ... "good" form of fat -- so called because it burns ...
... of new ways to treat obesity , , WEDNESDAY, Aug. ... also helps promote development of "good" brown fat that helps ... researchers at the Joslin Diabetes Center in Boston. , They ... lead to new ways to prevent and treat obesity. , ...
... Aug. 20 Digital health technologies designed to,monitor ... in U.S. revenues in,excess of $1.8 billion by ... in service and hardware,revenues, according to Parks Associates, ... medical, activity, and environmental,sensors and fitness measurement devices ...
... Aug. 20 Cord Blood America, Inc.,(OTC Bulletin ... preservation,company ( http://www.cordblood-america.com ) focused on bringing the ... and internationally,today reported that revenues for the first ... million., Revenues were down from the same ...
... fuels rapid growth by partnering with Flexicare Ltd., a ... intubation products]. , ... ... week that it had expanded its product offering of ...
... AggreWell™400 plate is a novel tool for standardizing the generation ... ... Vancouver, British Columbia (PRWEB) August 20, 2008 -- http://www.stemcell.com ... cell separation products and ancillary reagents for stem cell research, ...
Cached Medicine News:Health News:Making 'good' fat from muscle and vice versa 2Health News:Making 'good' fat from muscle and vice versa 3Health News:Bone Growth Protein Also Promotes 'Good' Fat 2Health News:Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013 2Health News:Cord Blood America Reports Six Month Financial Results 2Health News:ORSupply.com Introduces New Line of Products from Flexicare 2Health News:STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research 2
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... 15, 2014 Massachusetts General Hospital (MGH), the ... ) announced today that they have launched a ... therapeutic targets and develop novel therapies for inflammatory ... millions worldwide. The MGH-Broad-Amgen collaboration brings together scientists ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... compares favorably with endoscopic resection for advanced disease, and ... SUNNYVALE, Calif., June 3 Results from ... Digestive Disease Week (DDW) in Chicago this week, revealing ... the HALO ablation system for eradicating a pre-cancerous esophageal ...
... And All Subsequent Study Visits - , , ... Ltd., (DSP) announced today that positive results from a phase ... with schizophrenia have been published in The Journal of ... involving 180 patients with acute schizophrenia, evaluated a single fixed ...
Cached Medicine Technology:Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons 2Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons 3Definitive Outcomes of Radiofrequency Ablation for Barrett's Esophagus Using the HALO Ablation System Reported at the Digestive Disease Week Meeting for Gastroenterologists and Esophageal Surgeons 4Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 3Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 4
This is the modular VICTOR2 multilabel counter with the TR-fluorometry, stacker and robot loading options.The addition of a xenon flash lamp brings the time-resolved fluorescence counting mode to th...
Flexible and sensitive fluorescence/luminescence microplate reader for endpoint and kinetic...
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
... with a 25-microplate capacity ... and aspiration and dispense ... On-board software for user ... programs. External vacuum pump ...
Medicine Products: